[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2013100585A3 - Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif - Google Patents

Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif Download PDF

Info

Publication number
WO2013100585A3
WO2013100585A3 PCT/KR2012/011497 KR2012011497W WO2013100585A3 WO 2013100585 A3 WO2013100585 A3 WO 2013100585A3 KR 2012011497 W KR2012011497 W KR 2012011497W WO 2013100585 A3 WO2013100585 A3 WO 2013100585A3
Authority
WO
WIPO (PCT)
Prior art keywords
same
active ingredient
cancer composition
adonis amurensis
amurensis extract
Prior art date
Application number
PCT/KR2012/011497
Other languages
English (en)
Korean (ko)
Other versions
WO2013100585A2 (fr
Inventor
함영민
김길남
정용환
윤원종
박수영
오대주
Original Assignee
(재)제주테크노파크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (재)제주테크노파크 filed Critical (재)제주테크노파크
Priority to JP2014549998A priority Critical patent/JP2015503551A/ja
Priority to CN201280064752.3A priority patent/CN104220063B/zh
Publication of WO2013100585A2 publication Critical patent/WO2013100585A2/fr
Publication of WO2013100585A3 publication Critical patent/WO2013100585A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne un extrait d'Adonis amurensis présentant une activité anticancéreuse dans une cellule et des expérimentations animales, et une composition anticancéreuse l'utilisant comme principe actif.
PCT/KR2012/011497 2011-12-26 2012-12-26 Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif WO2013100585A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014549998A JP2015503551A (ja) 2011-12-26 2012-12-26 ミチノクフクジュソウ抽出物またはその有効物質を用いた抗癌剤組成物
CN201280064752.3A CN104220063B (zh) 2011-12-26 2012-12-26 利用细福寿草提取物或其有效物质的抗癌剂组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20110142072 2011-12-26
KR10-2011-0142072 2011-12-26

Publications (2)

Publication Number Publication Date
WO2013100585A2 WO2013100585A2 (fr) 2013-07-04
WO2013100585A3 true WO2013100585A3 (fr) 2013-08-22

Family

ID=48698749

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/011497 WO2013100585A2 (fr) 2011-12-26 2012-12-26 Extrait d'adonis amurensis ou composition anticancéreuse l'utilisant comme principe actif

Country Status (4)

Country Link
JP (1) JP2015503551A (fr)
KR (1) KR101530910B1 (fr)
CN (1) CN104220063B (fr)
WO (1) WO2013100585A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110343187B (zh) * 2019-07-30 2020-07-17 广州市爱百伊生物技术有限公司 一种天然多糖及祛斑美白用途
CN110372808B (zh) * 2019-07-30 2020-11-03 玛莉艾丝(广东)生命科技有限公司 一种祛斑美白活性多糖和用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206819A (ja) * 2000-01-24 2001-07-31 Sansho Seiyaku Co Ltd 美白化粧料
KR20030080459A (ko) * 2002-04-08 2003-10-17 송호엽 당뇨병제 및 제조방법
KR20110001538A (ko) * 2009-06-30 2011-01-06 한국콜마 주식회사 항산화 및 미백 활성을 갖는 꽃 혼합 추출물 및 그 추출방법 및 그 꽃 혼합 추출물을 함유하는 화장료 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206819A (ja) * 2000-01-24 2001-07-31 Sansho Seiyaku Co Ltd 美白化粧料
KR20030080459A (ko) * 2002-04-08 2003-10-17 송호엽 당뇨병제 및 제조방법
KR20110001538A (ko) * 2009-06-30 2011-01-06 한국콜마 주식회사 항산화 및 미백 활성을 갖는 꽃 혼합 추출물 및 그 추출방법 및 그 꽃 혼합 추출물을 함유하는 화장료 조성물

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KI HWAN, BAE ET AL.: "of angiogenesis inhibitors from Korean plants (1)", KOREAN JOURNAL OF PHARMACOGNOSY, vol. 31, no. 3, 2000, pages 320 - 324 *
YOU, YOUNG-JAE ET AL.: "Inhibitory effect of Adonis amurensis components on tube-like formation of human umbilical venous cells", PHYTOTHERAPY RESEARCH, vol. 17, 2003, pages 568 - 570 *

Also Published As

Publication number Publication date
CN104220063B (zh) 2016-06-08
CN104220063A (zh) 2014-12-17
JP2015503551A (ja) 2015-02-02
KR20130074768A (ko) 2013-07-04
KR101530910B1 (ko) 2015-06-23
WO2013100585A2 (fr) 2013-07-04

Similar Documents

Publication Publication Date Title
EP2899200A4 (fr) Peptide de pénétration cellulaire, conjugué le comprenant, et composition comprenant le conjugué
EP2899199A4 (fr) Peptide de pénétration cellulaire, conjugué le comprenant, et composition comprenant le conjugué
WO2013102144A8 (fr) Variants du polypeptide ph20, formulations en contenant et leurs utilisations
WO2014179629A3 (fr) Compositions et procédés
EA201500582A1 (ru) Тройные фунгицидные смеси
WO2012056457A3 (fr) COMPOSITIONS ET PROCÉDÉS D'ACTIVATION D'EXPRESSION PAR UN ARNmi ENDOGÈNE SPÉCIFIQUE
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2012077077A8 (fr) Mélanges fongicides
MX2016008448A (es) Conjugados de var2csa-farmaco.
WO2012129341A3 (fr) Détection d'une maladie chez les plantes
IL220894A (en) Combinations of active substances containing dihydroporone and abamctin
FR2967572B1 (fr) Composition cosmetique comprenant un polyphenol en association avec un sucre
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
HUE052174T2 (hu) Ként, egy inszekticidet és egy agrokémiai segédanyagot tartalmazó rovarirtó készítmény
WO2009112590A3 (fr) Substances actives qui augmentent le seuil d'activation de cellules immunitaires
WO2011122872A3 (fr) Composition comprenant du coumestrol ou un extrait de fèves contenant du coumestrol
WO2012002730A3 (fr) Composition hydratante et de blanchiment de la peau contenant des extraits de venin d'abeille
WO2012051328A3 (fr) Pesticides à activité tensioactive élevée
WO2014044342A8 (fr) Carbonate d'hydroxyde de magnésium en tant qu'excipient dans des préparations renfermant un principe actif
ZA201306090B (en) Pesticide composition comprising sulphur,an acaricide and an agrochemical excipient
WO2013029011A8 (fr) Procédés et compositions renfermant un peptide dérivé de l'extrémité c terminale de bax
GT200900006A (es) Derivados de piridazina novedosos
IL225440A (en) Cyclohexane derivatives, preparations containing them and their uses
WO2009047434A3 (fr) Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
WO2012036414A3 (fr) Composition cosmétique comprenant une fraction d'extrait de soja fermenté au titre de principe actif

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12861795

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014549998

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 12861795

Country of ref document: EP

Kind code of ref document: A2